Here are five takeaways:
1. Kohlberg & Company has acquired majority ownership of Amendia.
2. The firm plans to support Amendia’s growth initiatives with its $1.6 billion private equity fund, Kohlberg Investors VII.
3. Amedica also grew its senior management team:
• Chris Fair as COO and board of directors’ member
• Larry Boyd, PhD, as executive vice president of research and development
• Scott Bruder, MD, PhD, as a Kohlberg strategic advisor and a member of Amendia’s board of directors and executive committee
4. Amendia entered the partnership to position itself for accelerated growth and enhanced value propositions for customers and partners.
5. Amendia offers products to treat deformity and degenerative conditions.
More articles on devices:
Anika Therapeutics’ total revenue up 44% to $22.3M — 5 things to know
Zimmer Biomet, NuVasive, Wenzel Spine & more: 21 key notes
Stryker to launch Tritanium Posterior Lumbar Cage: 4 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.